Treatment planning in molecular radiotherapy
Open Access
- 1 December 2013
- journal article
- review article
- Published by Elsevier in Zeitschrift für Medizinische Physik
- Vol. 23 (4) , 262-269
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (GL236/7-2)
- Bundesministerium für Forschung, Technologie und Raumfahrt (BMBF-01EZ1130)
This publication has 63 references indexed in Scilit:
- The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- Differences in predicted and actually absorbed doses in peptide receptor radionuclide therapyMedical Physics, 2012
- Nuclear medicine dosimetry: Quantitative imaging and dose calculationsZeitschrift für Medizinische Physik, 2011
- Dosimetry prior to I-131-therapy of benign thyroid diseaseZeitschrift für Medizinische Physik, 2011
- Potential of Optimal Preloading in Anti-CD20 Antibody Radioimmunotherapy: An Investigation Based on Pharmacokinetic ModelingCancer Biotherapy and Radiopharmaceuticals, 2010
- Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An Introduction to the Scientific IssuesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- 124I PET-Based 3D-RD Dosimetry for a Pediatric Thyroid Cancer Patient: Real-Time Treatment Planning and Methodologic ComparisonJournal of Nuclear Medicine, 2009
- MIRD Pamphlet No. 20: The Effect of Model Assumptions on Kidney Dosimetry and Response—Implications for Radionuclide TherapyJournal of Nuclear Medicine, 2008
- Therapeutic Radionuclides: Biophysical and Radiobiologic PrinciplesSeminars in Nuclear Medicine, 2008
- EANM procedure guideline for treatment of refractory metastatic bone painEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008